EMMESSAR BIOTECH & NUTRITION LTD.

Emmessar Biotech & Nutrition Ltd, originally established on March 17, 1992, as Emmessar Chemical Industries Ltd (ECIL), commenced its operations by manufacturing Super Specialty Fine Chemicals. Through its in-house R&D efforts, the company successfully developed numerous Specialty Fine Chemicals. ECIL received official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New Delhi, in early 1996. Upon realizing that some of the specialty chemicals developed and exported to the USA & Europe were utilized in producing healthcare formulations, the company ventured into the Healthcare business, foreseeing significant growth in the upcoming decades. ECIL's research team determined that the specialty chemicals they produced had potential as 'Vital Micro Nutrients', widely utilized worldwide in biotechnology research. Seizing the opportunity, the company expanded into the field of Biotechnology & Healthcare, aligning with the global priority placed on healthcare by both manufacturers and consumers. To better reflect its new focus, the company underwent a name change from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000. EBNL's R&D continued its exploration, identifying potential markets for their healthcare products. In 1998, the company entered into a collaborative partnership with Vibrant Life, a reputable California-based company, leading to groundbreaking discoveries (VedaCeuticals) blending Nutraceuticals, Cosmeceuticals, Ayurveda, Biotechnology, and Nanotechnology. This collaboration brought new dimensions to future products emerging from EBNL. EBNL's product range addresses various aspects and unmet needs of Healthcare, targeting obstinate skin problems, muscle problems, bone problems, and other chronic physical ailments. EBNL, a Public Limited Company, has a paid-up Share Capital of about Rs. 50.00 million (over US$ 1.00 million), with its stocks traded on The Bombay Stock Exchange Ltd.